Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Shirota

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
The Tohoku Journal of Experimental Medicine|November 30, 2022
Suspected Immune Thrombocytopenic Purpura Induced by Lenalidomide for the Treatment of Myelodysplastic Syndrome with Deletion of Chromosome 5q: A Case ReportHaruna Furukawa, Jun Nomura, Masahiro Kobayashi, et al.
Iscience|June 8, 2026
DCIR-mediated inhibitory regulation of TLR7-MyD88 axis prevents autoimmune neuroinflammationAtsushi Fujioka, Kenji Shimizu, Saki Nakayama, et al.
The Tohoku Journal of Experimental Medicine|December 22, 2015
Extracorporeal Shock Wave Therapy for Digital Ulcers of Systemic Sclerosis: A Phase 2 Pilot StudyShinichiro Saito, Tomonori Ishii, Yukiko Kamogawa, et al.
Modern Rheumatology|January 25, 2018
Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosusTomonori Ishii, Yoshiya Tanaka, Atsushi Kawakami, et al.
Internal Medicine (Tokyo, Japan)|March 15, 2021
Spontaneous Regression of Blastic Plasmacytoid Dendritic Cell Neoplasm Following Sepsis by Serratia marcescens: A Case Report and Literature ReviewAkane Suzuki, Shori Abe, Kaori Koyama, et al.
BMC Rheumatology|February 26, 2025
A cohort study in HigAshi-nippon of Pulmonary hyPertensIoN in systEmic SclerosiS (HAPPINESS study): protocol and baseline data for an observational studyShuhei Takeyama, Hironari Hanaoka, Akiyoshi Hashimoto, et al.
Modern Rheumatology|November 19, 2024
Effectiveness and safety of low-energy shock wave therapy for digital ulcers associated with systemic sclerosis: A Phase 3 pivotal clinical trialTomonori Ishii, Yasushi Kawaguchi, Osamu Ishikawa, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
The Tohoku Journal of Experimental Medicine|November 30, 2022
Suspected Immune Thrombocytopenic Purpura Induced by Lenalidomide for the Treatment of Myelodysplastic Syndrome with Deletion of Chromosome 5q: A Case ReportHaruna Furukawa, Jun Nomura, Masahiro Kobayashi, et al.
Iscience|June 8, 2026
DCIR-mediated inhibitory regulation of TLR7-MyD88 axis prevents autoimmune neuroinflammationAtsushi Fujioka, Kenji Shimizu, Saki Nakayama, et al.
The Tohoku Journal of Experimental Medicine|December 22, 2015
Extracorporeal Shock Wave Therapy for Digital Ulcers of Systemic Sclerosis: A Phase 2 Pilot StudyShinichiro Saito, Tomonori Ishii, Yukiko Kamogawa, et al.
Modern Rheumatology|January 25, 2018
Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosusTomonori Ishii, Yoshiya Tanaka, Atsushi Kawakami, et al.
Internal Medicine (Tokyo, Japan)|March 15, 2021
Spontaneous Regression of Blastic Plasmacytoid Dendritic Cell Neoplasm Following Sepsis by Serratia marcescens: A Case Report and Literature ReviewAkane Suzuki, Shori Abe, Kaori Koyama, et al.
BMC Rheumatology|February 26, 2025
A cohort study in HigAshi-nippon of Pulmonary hyPertensIoN in systEmic SclerosiS (HAPPINESS study): protocol and baseline data for an observational studyShuhei Takeyama, Hironari Hanaoka, Akiyoshi Hashimoto, et al.
Modern Rheumatology|November 19, 2024
Effectiveness and safety of low-energy shock wave therapy for digital ulcers associated with systemic sclerosis: A Phase 3 pivotal clinical trialTomonori Ishii, Yasushi Kawaguchi, Osamu Ishikawa, et al.
Pageof 5